Aequus Pharmaceuticals (QB) Stock Price - AQSZF

0.0807
-0.0006 (-0.74%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Aequus Pharmaceuticals Inc (QB) AQSZF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0006 -0.74% 0.0807 0.0807 0.0807 0.0807 0.0813 16:19:42
Bid Price Ask Price Spread Spread % News
0.06 0.1386 0.0786 56.71% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2 56,801 $ 0.0807 $ 4,584 32,776 0.059 - 0.1847
Last Trade Time Type Quantity Stock Price Currency
11:43:03 45,301 $ 0.0807 USD

Aequus Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 6.49M 80.44M $ -2.80M - - 69.90M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
109.76k $ - 0.00% - -

more financials information »

Aequus Pharmaceuticals (QB) News

Loading Messages....

Latest AQSZF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AQSZF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.09690.100.078140.085840955,290-0.0162-16.72%
1 Month0.100.11080.078140.090833428,377-0.0193-19.3%
3 Months0.0990.11680.0590.086945237,150-0.0183-18.48%
6 Months0.109150.14620.0590.092533124,154-0.02845-26.07%
1 Year0.150.18470.0590.11547326,617-0.0693-46.2%
3 Years0.220.3560.0590.177258437,767-0.1393-63.32%
5 Years0.41090.56750.0590.194598136,102-0.3302-80.36%

Aequus Pharmaceuticals (QB) Description

Aequus Pharmaceuticals Inc. is a Vancouver-based specialty pharmaceutical company focused on developing, advancing and promoting differentiated products in Canada. Aequus development pipeline focuses on enhancing delivery methods for approved drugs that are limited by non-compliance, high frequency dosing, first-pass metabolism side-effects, painful injections, or where the therapeutic profile can be improved by making an alternative delivery system available. Aequus is developing several products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems. Aequus intends to commercialize its internal programs within Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide.


Your Recent History
USOTC
AQSZF
Aequus Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.